In colon cancer, PLIN2 supported LD formation upon FOX and 5-Fu treatments; LD accumulation could consequently avoid PD-L1 and PD-1 exposure to tumor and CD8+T cells, respectively, thus leading to immunotherapy failure in addition to FOX resistance (45). Here, PLIN2 is linked to malignant colon neoplasm.